3SBio Inc. (HKG: 1530)
Hong Kong
· Delayed Price · Currency is HKD
6.01
-0.20 (-3.22%)
Jan 28, 2025, 12:08 PM HKT
3SBio Revenue
3SBio had revenue of 4.39B CNY in the half year ending June 30, 2024, with 41.85% growth. This brings the company's revenue in the last twelve months to 8.42B, up 11.47% year-over-year. In the year 2023, 3SBio had annual revenue of 7.82B with 13.84% growth.
Revenue (ttm)
8.42B CNY
Revenue Growth
+11.47%
P/S Ratio
1.62
Revenue / Employee
1.56M CNY
Employees
5,411
Market Cap
14.15B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.82B | 950.20M | 13.84% |
Dec 31, 2022 | 6.87B | 483.73M | 7.58% |
Dec 31, 2021 | 6.38B | 794.37M | 14.22% |
Dec 31, 2020 | 5.59B | 269.55M | 5.07% |
Dec 31, 2019 | 5.32B | 734.22M | 16.02% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 26.04B |
Hansoh Pharmaceutical Group Company | 13.00B |
JD Health International | 58.84B |
WuXi Biologics | 18.39B |
Sinopharm Group | 634.32B |
Alibaba Health Information Technology | 31.39B |
Akeso | 2.01B |
Innovent Biologics | 8.01B |